Quantitative nanostructure-activity relationship modeling.
暂无分享,去创建一个
A. Tropsha | R. Weissleder | S. Shaw | D. Fourches | R. Mumper | C. Tassa | Dongqiuye Pu
[1] J. Farber,et al. ATP depletion and loss of cell integrity in anoxic hepatocytes and silica-treated P388D1 macrophages. , 1985, The American journal of physiology.
[2] Alexander Tropsha,et al. Novel Variable Selection Quantitative Structure-Property Relationship Approach Based on the k-Nearest-Neighbor Principle , 2000, J. Chem. Inf. Comput. Sci..
[3] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[4] Roberto Todeschini,et al. Handbook of Molecular Descriptors , 2002 .
[5] A. Tropsha,et al. Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates. , 2003, Journal of medicinal chemistry.
[6] John M. Barnard,et al. Clustering Methods and Their Uses in Computational Chemistry , 2003 .
[7] Jenny R. Roberts,et al. PbCrO4 mediates cellular responses via reactive oxygen species , 2004, Molecular and Cellular Biochemistry.
[8] M. Morandi,et al. Nanoparticle‐induced platelet aggregation and vascular thrombosis , 2005, British journal of pharmacology.
[9] R. Weissleder,et al. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules , 2005, Nature Biotechnology.
[10] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.
[11] J. Oh,et al. Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles , 2005, Pharmaceutical Research.
[12] Debra L Laskin,et al. Smaller is not always better: nanotechnology yields nanotoxicology. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[13] Alexander Golbraikh,et al. Predictive QSAR modeling workflow, model applicability domains, and virtual screening. , 2007, Current pharmaceutical design.
[14] Zoran Markovic,et al. Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene. , 2007, European journal of pharmacology.
[15] H. Krug,et al. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. , 2007, Toxicology letters.
[16] Dana Martin,et al. QSPR modeling of solubility of polyaromatic hydrocarbons and fullerene in 1-octanol and n-heptane. , 2007, The journal of physical chemistry. B.
[17] Zoran Markovic,et al. Modulation of Tumor Necrosis Factor-mediated Cell Death by Fullerenes , 2008, Pharmaceutical Research.
[18] B. Karn,et al. Green Nanotechnology: It’s Easier than You Think , 2007 .
[19] I. Tetko,et al. ISIDA - Platform for Virtual Screening Based on Fragment and Pharmacophoric Descriptors , 2008 .
[20] Igor V. Tetko,et al. Critical Assessment of QSAR Models of Environmental Toxicity against Tetrahymena pyriformis: Focusing on Applicability Domain and Overfitting by Variable Selection , 2008, J. Chem. Inf. Model..
[21] Aravind Subramanian,et al. Perturbational profiling of nanomaterial biologic activity , 2008, Proceedings of the National Academy of Sciences.
[22] Igor V. Tetko,et al. Combinatorial QSAR Modeling of Chemical Toxicants Tested against Tetrahymena pyriformis , 2008, J. Chem. Inf. Model..
[23] Mary Gulumian,et al. The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles , 2009, Particle and Fibre Toxicology.
[24] Su Jin Kang,et al. Titanium dioxide nanoparticles trigger p53‐mediated damage response in peripheral blood lymphocytes , 2008, Environmental and molecular mutagenesis.
[25] Jianzhong Liu,et al. Identification of possible sources of nanotoxicity from carbon nanotubes inserted into membrane bilayers using membrane interaction quantitative structure--activity relationship analysis. , 2008, Chemical research in toxicology.
[26] F. Collins,et al. Transforming Environmental Health Protection , 2008, Science.
[27] T. Puzyn,et al. Toward the development of "nano-QSARs": advances and challenges. , 2009, Small.
[28] Bryce J Marquis,et al. Analytical methods to assess nanoparticle toxicity. , 2009, The Analyst.
[29] Pawel L Urban,et al. Nanoparticles: their potential toxicity, waste and environmental management. , 2009, Waste management.
[30] Anton J Hopfinger,et al. Affinity of drugs and small biologically active molecules to carbon nanotubes: a pharmacodynamics and nanotoxicity factor? , 2009, Molecular pharmaceutics.
[31] JF Nyland,et al. A nanobiological approach to nanotoxicology , 2009, Human & experimental toxicology.
[32] M. Heinemann,et al. Guidance for handling and use of nanomaterials at the workplace , 2009, Human & experimental toxicology.
[33] Yoo-Hun Suh,et al. Nanotechnology, nanotoxicology, and neuroscience , 2009, Progress in Neurobiology.
[34] Saji George,et al. A predictive toxicological paradigm for the safety assessment of nanomaterials. , 2009, ACS nano.
[35] T. Xia,et al. Potential health impact of nanoparticles. , 2009, Annual review of public health.
[36] V. Kagan,et al. The role of nanotoxicology in realizing the ‘helping without harm’ paradigm of nanomedicine: lessons from studies of pulmonary effects of single‐walled carbon nanotubes , 2010, Journal of internal medicine.
[37] Alexander Tropsha,et al. Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research , 2010, J. Chem. Inf. Model..
[38] Alexander Tropsha,et al. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. , 2010, Chemical research in toxicology.
[39] Lenore L. Dai,et al. Understanding nanoparticle diffusion and exploring interfacial nanorheology using molecular dynamics simulations. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[40] G. Oberdörster,et al. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology , 2010, Journal of internal medicine.